411 related articles for article (PubMed ID: 34440819)
1. Hematopoietic Dysfunction during Graft-Versus-Host Disease: A Self-Destructive Process?
Müskens KF; Lindemans CA; Belderbos ME
Cells; 2021 Aug; 10(8):. PubMed ID: 34440819
[TBL] [Abstract][Full Text] [Related]
2. Concise review: the bone marrow niche as a target of graft versus host disease.
von Bonin M; Bornhäuser M
Stem Cells; 2014 Jun; 32(6):1420-8. PubMed ID: 24585665
[TBL] [Abstract][Full Text] [Related]
3. Severe hematopoietic alterations in vitro, in bone marrow transplant recipients who develop graft-versus-host disease.
Martínez-Jaramillo G; Gómez-Morales E; Sánchez-Valle E; Mayani H
J Hematother Stem Cell Res; 2001 Jun; 10(3):347-54. PubMed ID: 11454310
[TBL] [Abstract][Full Text] [Related]
4. How does transfusion-associated graft-versus-host disease compare to hematopoietic cell transplantation-associated graft-versus-host disease?
Aizawa K; Peltier D; Matsuki E; Toubai T
Transfus Apher Sci; 2022 Apr; 61(2):103405. PubMed ID: 35210194
[TBL] [Abstract][Full Text] [Related]
5. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow graft-versus-host disease: early destruction of hematopoietic niche after MHC-mismatched hematopoietic stem cell transplantation.
Shono Y; Ueha S; Wang Y; Abe J; Kurachi M; Matsuno Y; Sugiyama T; Nagasawa T; Imamura M; Matsushima K
Blood; 2010 Jul; 115(26):5401-11. PubMed ID: 20354171
[TBL] [Abstract][Full Text] [Related]
7. Infusion of endothelial progenitor cells accelerates hematopoietic and immune reconstitution, and ameliorates the graft-versus-host disease after hematopoietic stem cell transplantation.
Zeng L; Chen C; Song G; Yan Z; Xu S; Jia L; Ding S; Cao J; Chen W; Cheng H; Li Z; Sang W; Wang L; Li Y; Xu K
Cell Biochem Biophys; 2012 Dec; 64(3):213-22. PubMed ID: 22806343
[TBL] [Abstract][Full Text] [Related]
8. Nonclassical manifestations of acute GVHD.
Zeiser R; Teshima T
Blood; 2021 Dec; 138(22):2165-2172. PubMed ID: 34482399
[TBL] [Abstract][Full Text] [Related]
9. TNFAIP8 Deficiency Exacerbates Acute Graft Versus Host Disease in a Murine Model of Allogeneic Hematopoietic Cell Transplantation.
Kumari R; Palaniyandi S; Strattan E; Huang T; Kohler K; Jabbour N; Dalland J; Du J; Kesler MV; Chen YH; Hildebrandt GC
Transplantation; 2020 Mar; 104(3):500-510. PubMed ID: 31634333
[TBL] [Abstract][Full Text] [Related]
10. Acute graft versus host disease in hematopoietic stem cell alotransplant recipients.
Krstevska S; Genadieva-Stavric S; Pivkova A; Stojanovski Z; Georgievski B; Balkanov T
Med Arh; 2011; 65(5):260-4. PubMed ID: 22073847
[TBL] [Abstract][Full Text] [Related]
11. Acute graft-vs-host disease: pathobiology and management.
Goker H; Haznedaroglu IC; Chao NJ
Exp Hematol; 2001 Mar; 29(3):259-77. PubMed ID: 11274753
[TBL] [Abstract][Full Text] [Related]
12. Reconstitution of self-tolerance after hematopoietic stem cell transplantation.
Hess AD
Immunol Res; 2010 Jul; 47(1-3):143-52. PubMed ID: 20066509
[TBL] [Abstract][Full Text] [Related]
13. Potential Use of Mesenchymal Multipotent Cells for Hemopoietic Stem Cell Transplantation: Pro and Contra.
Kiselevskiy M; Vlasenko R; Reshetnikova V; Chikileva I; Shubina I; Osmanov E; Valiev T; Sidorova N; Batmanova N; Stepanyan N; Kirgizov K; Varfolomeeva S
J Pediatr Hematol Oncol; 2021 Apr; 43(3):90-94. PubMed ID: 33560076
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic Th1 cells home to host bone marrow and spleen and mediate IFNγ-dependent aplasia.
Chewning JH; Zhang W; Randolph DA; Swindle CS; Schoeb TR; Weaver CT
Biol Blood Marrow Transplant; 2013 Jun; 19(6):876-87. PubMed ID: 23523972
[TBL] [Abstract][Full Text] [Related]
15. Numerical impairment of nestin(+) bone marrow niches in acute GvHD after allogeneic hematopoietic stem cell transplantation for AML.
Medinger M; Krenger W; Jakab A; Halter J; Buser A; Bucher C; Passweg J; Tzankov A
Bone Marrow Transplant; 2015 Nov; 50(11):1453-8. PubMed ID: 26301968
[TBL] [Abstract][Full Text] [Related]
16. Histological evaluation of acute mucocutaneous graft-versus-host disease in nonmyeloablative hematologic stem cell transplants with an observation predicting an increased risk of progression to chronic graft-versus-host disease.
Bridge AT; Nelson RP; Schwartz JE; Mirowski GW; Billings SD
Am J Dermatopathol; 2007 Feb; 29(1):1-6. PubMed ID: 17284954
[TBL] [Abstract][Full Text] [Related]
17. Blockade of TIM-1 on the donor graft ameliorates graft-versus-host disease following hematopoietic cell transplantation.
Iliopoulou BP; Hsu K; Pérez-Cruz M; Tang SW; Pang WW; Erkers T; Kambham N; Freeman GJ; Dekruyff RH; Meyer EH
Blood Adv; 2019 Nov; 3(21):3419-3431. PubMed ID: 31714958
[TBL] [Abstract][Full Text] [Related]
18. [Disruption of gut immune system caused by damage of intestinal stem cells and their niche in graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.].
Hayase E; Teshima T
Clin Calcium; 2017; 27(6):829-833. PubMed ID: 28536321
[TBL] [Abstract][Full Text] [Related]
19. Novel Scoring Criteria for the Evaluation of Ocular Graft-versus-Host Disease in a Preclinical Allogeneic Hematopoietic Stem Cell Transplantation Animal Model.
Perez VL; Barsam A; Duffort S; Urbieta M; Barreras H; Lightbourn C; Komanduri KV; Levy RB
Biol Blood Marrow Transplant; 2016 Oct; 22(10):1765-1772. PubMed ID: 27492793
[TBL] [Abstract][Full Text] [Related]
20. Role of cytokines in the pathophysiology of acute graft-versus-host disease (GVHD): are serum/plasma cytokines potential biomarkers for diagnosis of acute GVHD following allogeneic hematopoietic cell transplantation (Allo-HCT)?
Toubai T; Tanaka J; Paczesny S; Shono Y; Reddy P; Imamura M
Curr Stem Cell Res Ther; 2012 May; 7(3):229-39. PubMed ID: 22023620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
